Financial Reporting · Ind AS 102 Share Based Payment
Modification, Cancellation and Settlement of Awards under Ind AS 102
Updated 5 October 2026 · Fact-checked
Under Ind AS 102, a modified equity-settled award is expensed at least at its original grant-date fair value. If the modification raises fair value, you also recognise the incremental fair value over the remaining vesting period. A cancellation or settlement is treated as acceleration of vesting, and any payment up to fair value is charged to equity.
Understand Modification, Cancellation and Settlement of Awards
An entity grants options, then conditions change. The share price falls and options go out of the money, so the entity reprices them. Or it changes the vesting period. Or it cancels the grant. Ind AS 102 asks one question: did the change benefit the employee or not?
The core rule protects the original expense. For equity-settled awards you must recognise, as a minimum, the services measured at the grant-date fair value, unless the awards do not vest because of a vesting condition (other than a market condition) that was specified at grant date. A downward repricing of the exercise price is a beneficial modification. The original grant-date expense is still recognised, and the incremental fair value is added on top. Management cannot reduce the expense by a modification.
Market conditions work differently. If an award fails to vest only because a market condition (for example, a target share price) is not met, you do not reverse the expense, provided the employee has met all service and non-market performance conditions. You reverse expense only when a service condition or a non-market performance condition is not met.
If the modification is beneficial, you recognise the extra value. Beneficial means it increases the fair value of the instrument (for example, a lower exercise price), increases the number of instruments, or changes vesting conditions in the employee's favour. The incremental fair value is the fair value of the modified instrument minus the fair value of the original instrument, both measured at the modification date. It is recognised over the period from modification date to the end of the modified vesting period, in addition to the original expense.
If the modification is not beneficial, such as making vesting conditions harder, you carry on as if it never happened. You keep accounting for the original grant. One exception: a reduction in the number of instruments granted is accounted for as a cancellation of that portion, so the unrecognised expense for that portion is accelerated.
A cancellation or settlement during the vesting period is treated as acceleration of vesting. You immediately recognise the amount that would otherwise have been recognised over the remaining period. Any payment to the employee up to the fair value of the instruments at cancellation date is a deduction from equity (repurchase of an equity interest). Any excess over that fair value is an expense. If new awards are granted and identified as replacing the cancelled ones, treat it as a modification.
Key rules to remember
- Minimum expense
- Total expense ≥ grant-date fair value of original award × number of instruments for which service and non-market vesting conditions are met
- Applies to equity-settled awards even after repricing. Expense is reversed only if a service or non-market performance condition is not met. If only a market condition is not met, the expense already recognised is not reversed.
- Incremental fair value
- Incremental FV = FV of modified instrument − FV of original instrument (both at modification date)
- Recognised over the period from modification date to the end of the modified vesting period, over and above the original expense.
- Replacement award
- Incremental FV = Net FV of replacement instrument − Net FV of cancelled instrument at replacement date
- Applies only when the entity identifies the new award as a replacement for a cancelled one.
- Cancellation or settlement
- Immediate expense = Amount not yet recognised for the award
- Treated as acceleration of vesting. Payment up to fair value at cancellation date is debited to equity; any excess is an expense.
- Non-beneficial modification
- Expense continues on original grant-date fair value
- Applies to changes such as a higher exercise price or harder vesting conditions, which are ignored. A reduction in the number of options is not ignored: treat it as a cancellation of that portion and accelerate its unrecognised expense.
How to solve Modification, Cancellation and Settlement of Awards questions
Use this order for any question on modification, cancellation or settlement of an equity-settled award.
- 1Identify the event: modification, cancellation or settlement, and its date. Check whether a replacement award is identified.
- 2Compute the original expense on grant-date fair value for the years up to the event, based on the best estimate of awards expected to vest.
- 3For a modification, decide if it is beneficial: higher fair value, more instruments, or easier vesting conditions.
- 4If beneficial, compute incremental fair value at the modification date and spread it over the remaining modified vesting period.
- 5If not beneficial (for example, a higher exercise price or harder vesting conditions), ignore the change and keep the original grant-date fair value expense. Treat any reduction in the number of options as a cancellation of that portion.
- 6For cancellation or settlement, accelerate the unrecognised expense immediately. Compare any payment with the fair value at cancellation date.
- 7Build the year-wise expense: original charge plus incremental charge. Pass the entries as Dr Employee benefits expense, Cr Share-based payment reserve (equity).
- 8Re-estimate the number of employees expected to vest each year and true up the cumulative expense.
Quickest way: Three-line check for modification questions
When to use it: Use when time is short and the question gives fair values at the modification date.
- Write the original annual charge: grant-date fair value × options expected to vest ÷ vesting years.
- Write the incremental charge: (modified FV − original FV) × options expected to vest ÷ remaining years after modification.
- Add the two for each year after modification. For cancellation, put the entire unrecognised balance in the cancellation year and check what is paid against the fair value.
Common mistakes in Modification, Cancellation and Settlement of Awards
Revaluing the original option to the new, lower fair value after the share price falls.
Students think the expense should follow current value.
Fix: Equity-settled awards stay at grant-date fair value. Only the incremental fair value at modification date is added.
Treating a downward repricing of the exercise price as ignored, or as a way to reduce the expense.
Students link the fall in share price to a lower charge and forget that a lower exercise price helps the employee.
Fix: A lower exercise price raises fair value, so it is a beneficial modification. Keep the original grant-date expense and add the incremental fair value on top. Repricing can never reduce the expense.
Measuring incremental fair value as modified fair value minus grant-date fair value.
The grant-date figure is easy to see in the question.
Fix: Both fair values must be taken at the modification date. Compare the repriced option with the old option on that same date.
Spreading the incremental fair value over the original total vesting period.
Students reuse the original period automatically.
Fix: Spread it from the modification date to the end of the modified vesting period.
Reducing the expense when options are repriced at a higher exercise price or vesting is made harder.
Students assume a modification always changes the charge.
Fix: These non-beneficial changes are ignored. Keep recognising the original expense. The one exception is a reduction in the number of options, which is treated as a cancellation of that portion, so its unrecognised expense is accelerated.
Charging the whole cancellation payment to profit or loss.
Cash paid feels like an expense.
Fix: Payment up to the fair value of the cancelled award at cancellation date goes to equity. Only the excess is an expense.
Worked examples
Example 1
On 1 April 2025, Veda Ltd granted 1,000 options each to 100 employees, vesting after 3 years of service. Grant-date fair value is ₹30 per option. On 1 April 2026, the share price falls, and the exercise price is reduced. Fair value of an option at that date is ₹12 under the old terms and ₹20 under the new terms. The vesting period is unchanged. At each year-end, 90 employees are expected to vest, and the actual number is 90. Compute the expense for each year.
Show the solution
- Options expected to vest = 90 × 1,000 = 90,000.
- Original annual expense = 90,000 × ₹30 ÷ 3 = ₹9,00,000 per year.
- The repricing raises fair value, so it is beneficial. Incremental fair value = ₹20 − ₹12 = ₹8 per option.
- Total incremental cost = 90,000 × ₹8 = ₹7,20,000, spread over the 2 remaining years = ₹3,60,000 per year.
- Year 1 (2025-26): original charge only = ₹9,00,000.
- Year 2 (2026-27): ₹9,00,000 + ₹3,60,000 = ₹12,60,000.
- Year 3 (2027-28): ₹9,00,000 + ₹3,60,000 = ₹12,60,000.
Answer: Expense: ₹9,00,000 in 2025-26, ₹12,60,000 in 2026-27 and ₹12,60,000 in 2027-28. Total = ₹34,20,000, being ₹27,00,000 original plus ₹7,20,000 incremental.
Example 2
Rishi Ltd granted 50,000 options on 1 April 2025 with grant-date fair value ₹40 each, vesting over 4 years. All employees are expected to stay. On 31 March 2027, after two years, the entity cancels the entire grant and pays employees ₹30 per option in cash. Fair value of an option at cancellation date is ₹35. No replacement award is granted. Show the accounting.
Show the solution
- Total grant-date value = 50,000 × ₹40 = ₹20,00,000. Normal annual charge = ₹20,00,000 ÷ 4 = ₹5,00,000.
- Year 1 (2025-26): normal charge = ₹5,00,000. Year 2 (2026-27): normal charge = ₹5,00,000. The normal charges for the two years up to the cancellation date total ₹10,00,000.
- Unrecognised balance at cancellation = ₹20,00,000 − ₹10,00,000 = ₹10,00,000.
- The cancellation on 31 March 2027 is treated as acceleration of vesting, so the unrecognised ₹10,00,000 is expensed immediately. Expense for 2026-27 = ₹5,00,000 (year-2 normal charge) + ₹10,00,000 (acceleration) = ₹15,00,000.
- With ₹5,00,000 expensed in 2025-26 and ₹15,00,000 in 2026-27, the whole grant-date value of ₹20,00,000 has been recognised, and the share-based payment reserve stands at ₹20,00,000.
- Cash paid = 50,000 × ₹30 = ₹15,00,000. It is below the fair value of 50,000 × ₹35 = ₹17,50,000, so the whole payment is a repurchase of an equity interest and is debited to equity. There is no additional expense.
- Entry: Dr Share-based payment reserve ₹15,00,000, Cr Cash ₹15,00,000. The remaining ₹5,00,000 of the reserve stays in equity and may be transferred within equity.
Answer: The full ₹20,00,000 is expensed by 31 March 2027: ₹5,00,000 in 2025-26 and ₹15,00,000 in 2026-27 (the ₹5,00,000 year-2 normal charge plus ₹10,00,000 accelerated). The ₹15,00,000 payment is debited to equity, with no extra expense because it is below fair value.
Exam tips
- Always state the date at which each fair value is measured. Examiners award marks for this.
- Show year-wise expense in a small working: original charge, incremental charge, total. Do not give only the final figure.
- In case MCQs, check first whether the modification is beneficial. Many options trap you with a non-beneficial change.
- For cancellation, compare payment with fair value at cancellation date before choosing between equity and expense.
- Write the Ind AS 102 rule in one line, then apply it to the facts, then conclude.
Practice questions from Ind AS 102 Share Based Payment
- Anand Motors Ltd applies the amendments made to Ind AS 102 by Amendments to Classification and Measurement of Share-based Payment Transactio…
- Ravi Enterprises Ltd's accountant asks where the transitional provisions for first-time adopters relating to share-based payment are located…
- Parent company Veda Industries Ltd grants its own equity shares as options to employees of its subsidiary, Veda Components Ltd. The subsidia…
- Sagar Foods Ltd adopted Ind AS and has share-based payment arrangements. The Ind AS 102 amendments on Classification and Measurement of Shar…
- Subsidiary Kaveri Pharma Ltd receives services from its employees. Its parent, Himalaya Holdings Ltd, grants the employees rights to shares …
Modification, Cancellation and Settlement of Awards in other exams
The same ground in other exams, if you are preparing for more than one or want another angle on it.
Modification, Cancellation and Settlement of Awards: frequently asked questions
What is incremental fair value in Ind AS 102?
It is the fair value of the modified equity instrument minus the fair value of the original instrument, both at the modification date. You recognise it over the period from modification date to the end of the modified vesting period. It is added to the original expense.
Can an entity reduce the expense by repricing options downward?
No. Ind AS 102 requires at least the grant-date fair value of the original award to be recognised for equity-settled awards. A downward repricing of the exercise price is beneficial because it raises fair value. The original expense is still recognised and the incremental fair value is added on top. The expense is reversed only if the award fails to vest because a service or non-market performance condition is not met. If only a market condition is not met, the expense is not reversed.
How is cancellation of an ESOP treated?
A cancellation or settlement during vesting is treated as acceleration of vesting. The amount not yet recognised is expensed immediately. Payment up to fair value at cancellation date is charged to equity, and any excess is an expense.
What if new options are granted in place of cancelled ones?
If the entity identifies the new options as replacing the cancelled ones on the grant date, you treat it as a modification. The incremental fair value is the net fair value of the replacement minus the net fair value of the cancelled instrument at that date.